Home

Treatment

Read time: 3 min

Congress highlights

If at first you don’t succeed, try another CGRP antibody for migraine prevention?

If the first monoclonal antibody targeting calcitonin gene-related peptide fails to adequately...

Read time: 3 min

Congress highlights

Should antipsychotic medications be stopped as early as possible after the first episode?

Should antipsychotic drugs be discontinued as early as possible after the first episode - Yes or No...

Read time: 3 min

Satellite symposium

Small steps for big impact in treatment of schizophrenia

Functional recovery is an important goal in treating schizophrenia, but one that can be hard to...

Read time: 2 min

Congress highlights

Cytokine dysregulation in schizophrenia

Studies continue to indicate a multifaceted relationship between immunological and inflammatory...

Read time: 2 min

Congress highlights

Headache is an early symptom of Covid-19, often with migraine features

Headache is emerging as one of the most frequent neurological symptoms of Covid-19 reported in up...

Read time: 4 min

Congress highlights

Social isolation and stigma: Cross-cultural perspectives

Meaningful connection to other people is as essential to health as the air we breathe. So the...

Read time: 2 min

Congress highlights

The link between myelination, psychosis and antipsychotics

The hypothesis that myelin alterations play a critical role in the development of psychosis is...

Read time: 2 min

Why do antidepressants cause emotional blunting and what can be done to resolve it in clinical practice?

Emotional blunting describes an indifferent, unresponsive affect and inability to feel emotions...

Read time: 2 min

Congress highlights

CGRP has a role in infection-induced pain

While the role of calcitonin gene-related peptide (CGRP) in headache and migraine is well...

Read time: 3 min

Congress highlights

Community lifestyle interventions – making them work in schizophrenia

The considerable health disparities noted in those with schizophrenia compared to those living...

Read time: 2 min

Congress highlights

Promising biomarkers for predicting, monitoring and measuring treatment response

Imaging, blood and digital biomarkers for mental disorders can be used to predict, monitor and...

Read time: 3 min

Congress highlights

Why is migraine the second most disabling disease worldwide?

Migraine affects all areas of life. Its sudden unpredictable onset with severe incapacitating...

Read time: 3 min

Congress highlights

One disease or many – the complexity of major depressive disorder

Should we consider major depressive disorder as a single disease entity of a collection of...

Neurotoriun

Neurotorium is your new point of reference for educational content on psychiatry, neurology, and neuroscience.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

You are leaving Progress in Mind

Continue to

Cancel

Progress in Mind Belux

Accept Cancel

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intended for health care professionals.

All the information included in the Website is related to diseases, investigations and existing or potential treatment options and, therefore, directed to health professionals . The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country